Major Companies for Protein-based Drug Market: AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, Regeneron, Innovent, Hengrui Medicine, Sanofi, Sobi, Kanghong Pharma.
Global Protein-based Drug Market Size was estimated at USD 2171.7 million in 2022 and is projected to reach USD 2844.39520950603 million by 2028, exhibiting a CAGR of 4.6% during the forecast period.
Global Protein-based Drug Market Overview And Scope:
The Global Protein-based Drug Market Report 2024 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Protein-based Drug utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2024 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Protein-based Drug Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Protein-based Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Protein-based Drug market.
Global Protein-based Drug Market Segmentation
By Type, Protein-based Drug market has been segmented into:
Antibody-based Drugs
Fc Fusion Proteins
Anticoagulants
Blood Factors
Other
By Application, Protein-based Drug market has been segmented into:
Immune Diseases
Cancer
Other
Regional Analysis of Protein-based Drug Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Protein-based Drug Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Protein-based Drug market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Protein-based Drug market.
Major Companies Covered in Protein-based Drug market are:
AbbVie
Johnson & Johnson
Novartis
Gilead Sciences
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Merck & Co
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer
Regeneron
Innovent
Hengrui Medicine
Sanofi
Sobi
Kanghong Pharma
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Protein-based Drug Market by Type
5.1 Protein-based Drug Market Overview Snapshot and Growth Engine
5.2 Protein-based Drug Market Overview
5.3 Antibody-based Drugs
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Antibody-based Drugs: Geographic Segmentation
5.4 Fc Fusion Proteins
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Fc Fusion Proteins: Geographic Segmentation
5.5 Anticoagulants
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Anticoagulants: Geographic Segmentation
5.6 Blood Factors
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Blood Factors: Geographic Segmentation
5.7 Other
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Other: Geographic Segmentation
Chapter 6: Protein-based Drug Market by Application
6.1 Protein-based Drug Market Overview Snapshot and Growth Engine
6.2 Protein-based Drug Market Overview
6.3 Immune Diseases
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Immune Diseases: Geographic Segmentation
6.4 Cancer
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Cancer: Geographic Segmentation
6.5 Other
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Other: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Protein-based Drug Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Protein-based Drug Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Protein-based Drug Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ABBVIE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 JOHNSON & JOHNSON
7.4 NOVARTIS
7.5 GILEAD SCIENCES
7.6 ROCHE
7.7 BRISTOL-MYERS SQUIBB
7.8 AMGEN
7.9 ASTRAZENECA
7.10 MERCK & CO
7.11 TAKEDA
7.12 MERCK KGAA
7.13 SEAGEN
7.14 ELI LILLY
7.15 ONO PHARMACEUTICAL
7.16 PFIZER
7.17 REGENERON
7.18 INNOVENT
7.19 HENGRUI MEDICINE
7.20 SANOFI
7.21 SOBI
7.22 KANGHONG PHARMA
Chapter 8: Global Protein-based Drug Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Antibody-based Drugs
8.2.2 Fc Fusion Proteins
8.2.3 Anticoagulants
8.2.4 Blood Factors
8.2.5 Other
8.3 Historic and Forecasted Market Size By Application
8.3.1 Immune Diseases
8.3.2 Cancer
8.3.3 Other
Chapter 9: North America Protein-based Drug Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Antibody-based Drugs
9.4.2 Fc Fusion Proteins
9.4.3 Anticoagulants
9.4.4 Blood Factors
9.4.5 Other
9.5 Historic and Forecasted Market Size By Application
9.5.1 Immune Diseases
9.5.2 Cancer
9.5.3 Other
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Protein-based Drug Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Antibody-based Drugs
10.4.2 Fc Fusion Proteins
10.4.3 Anticoagulants
10.4.4 Blood Factors
10.4.5 Other
10.5 Historic and Forecasted Market Size By Application
10.5.1 Immune Diseases
10.5.2 Cancer
10.5.3 Other
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Protein-based Drug Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Antibody-based Drugs
11.4.2 Fc Fusion Proteins
11.4.3 Anticoagulants
11.4.4 Blood Factors
11.4.5 Other
11.5 Historic and Forecasted Market Size By Application
11.5.1 Immune Diseases
11.5.2 Cancer
11.5.3 Other
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Protein-based Drug Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Antibody-based Drugs
12.4.2 Fc Fusion Proteins
12.4.3 Anticoagulants
12.4.4 Blood Factors
12.4.5 Other
12.5 Historic and Forecasted Market Size By Application
12.5.1 Immune Diseases
12.5.2 Cancer
12.5.3 Other
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Protein-based Drug Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Antibody-based Drugs
13.4.2 Fc Fusion Proteins
13.4.3 Anticoagulants
13.4.4 Blood Factors
13.4.5 Other
13.5 Historic and Forecasted Market Size By Application
13.5.1 Immune Diseases
13.5.2 Cancer
13.5.3 Other
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Protein-based Drug Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Antibody-based Drugs
14.4.2 Fc Fusion Proteins
14.4.3 Anticoagulants
14.4.4 Blood Factors
14.4.5 Other
14.5 Historic and Forecasted Market Size By Application
14.5.1 Immune Diseases
14.5.2 Cancer
14.5.3 Other
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Protein-based Drug Scope:
|
Report Data
|
Protein-based Drug Market
|
|
Protein-based Drug Market Size in 2022
|
USD 2171.7 million
|
|
Protein-based Drug CAGR 2023 - 2030
|
4.6%
|
|
Protein-based Drug Base Year
|
2022
|
|
Protein-based Drug Forecast Data
|
2023 - 2030
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, Regeneron, Innovent, Hengrui Medicine, Sanofi, Sobi, Kanghong Pharma.
|
|
Key Segments
|
By Type
Antibody-based Drugs
Fc Fusion Proteins
Anticoagulants
Blood Factors
Other
By Applications
Immune Diseases
Cancer
Other
|
